Clinical guidelines & publications library
Guidance and publications produced by the RANZCP. Filter by type, topic, date or category.
-
Electronic media recording and storage
Ethics, Patient privacy & consent, Professionalism
This guideline was rescinded in May 2023. PDF Clinical guideline
Clinical guideline- Last updated: Aug 2007
- Published in Australia
- PPG #13
- Rescinded
-
Use of benzodiazepines in psychiatric practice
Benzodiazepines, Ethics, Professionalism
The RANZCP has developed this guidance for clinicians considering pharmacological treatment using benzodiazepines. PDF Clinical guideline
Clinical guideline- Last updated: Nov 2019
- Published in Australia
- PPG #5
-
Psychotropic medication use in children and adolescents
Antidepressants, Children & adolescents, Ethics, Professionalism
Before utilising psychotropic medication in children and adolescents, the RANZCP recommends that these guidelines be followed. PDF Clinical guideline
Clinical guideline- Last updated: Nov 2015
- Published in Australia
- PPG #7
-
ECT treatment during the COVID-19 pandemic
Electroconvulsive therapy & neurostimulation, Professionalism
Considerations and precautions for the delivery of ECT during the pandemic. PDF Clinical guideline
Clinical guideline- Last updated: Aug 2022
- Published in Australia
-
rTMS therapy during the COVID-19 pandemic
COVID-19, Electroconvulsive therapy & neurostimulation, Professionalism
PDF Clinical guideline
Clinical guideline- Last updated: Aug 2022
- Published in Australia
-
Deep brain stimulation
Electroconvulsive therapy & neurostimulation, Ethics, Professionalism
A clinical memorandum to inform psychiatrists who are interested in using Deep Brain Stimulation (DBS) as a treatment for psychiatric disorders. PDF Clinical guideline
Clinical guideline- Last updated: Jul 2022
- Published in Australia
-
Antipsychotic medications as a treatment of behavioural and psychological symptoms of dementia
Dementia, Professionalism
This guideline has been rescinded pending review. PDF Clinical guideline
Clinical guideline- Last updated: Aug 2016
- Published in Australia
- PPG #10
- Rescinded
-
Ethics and conduct
- Last updated: Jun 2022
- Published in Australia
-
Ethics and conduct
- Last updated: Nov 2018
- Published in Australia
- Current
-
Psychiatrists, general practitioners and psychologists
GPs and psychiatrists, Professionalism
Best practice referral, communication and shared care arrangements between psychiatrists, general practitioners and psychologists PDF Clinical guideline
Clinical guideline- Last updated: Apr 2014
- Published in Australia
-
Illicit drugs policy
Ethics, Illicit drugs, Professionalism
This joint statement from RACP and RANZCP is for individuals and organisations in Australia and New Zealand involved in the development of policies and programs concerned with illicit drug problems. PDF Clinical guideline
Clinical guideline- Last updated: Feb 2006
- Published in Australia
-
Use of ketamine in psychiatric practice
Ethics, Ketamine, Professionalism
Information for psychiatrists about the potential utility of ketamine in psychiatric practice. PDF Clinical guideline
Clinical guideline- Last updated: Apr 2025
- Published in Australia
- PPG# 24
-
Medical benefits for psychiatric treatment and training
Medicare, Professionalism
Professional Practice Guideline 1: Medical benefits for psychiatric treatment and training was rescinded in May 2025.
Clinical guideline- Last updated: May 2025
- Published in Australia
- PPG #1
- Rescinded
-
National codes and standards relevant to psychiatry practice and mental health services in Australia and New Zealand
Addressing health inequity, Culturally safe practice, Ethics, Health service standards, Professionalism
Professional Practice Guideline 14 was rescinded in May 2024. PDF Clinical guideline
Clinical guideline- Last updated: May 2024
- Published in Australia
- PPG #14
- Rescinded
-
Off-label prescribing in psychiatry
Ethics, Off-label prescribing, Professionalism
The Royal Australian New Zealand College of Psychiatrists (RANZCP) has developed this
guidance to provide advice to psychiatrists who may be considering the use of medications ‘off label’, with a key focus on risk identification and justification. PDF Clinical guidelineClinical guideline- Last updated: Dec 2023
- Published in Australia
- PPG #4
-
Administration of repetitive transcranial magnetic stimulation (rTMS)
Electroconvulsive therapy & neurostimulation, Ethics, Professionalism
Guidance on key professional practice issues that psychiatrists should consider when prescribing and administering repetitive transcranial magnetic stimulation (rTMS). PDF Clinical guideline
Clinical guideline- Last updated: May 2024
- Published in Australia
- PPG #16
-
Zero tolerance policy on proven sexual boundary violations
Ethics, Professionalism
PDF Ethics and conduct
Ethics and conduct- Last updated: Mar 2024
- Published in Australia
- Ethical guideline 12
- Current
-
Guidance for the use of stimulant medications in adults
Ethics, Professionalism, Stimulant medications
The RANZCP supports the appropriate use of these drugs in the treatment of attention deficit hyperactivity disorder (ADHD) and narcolepsy in adults. PDF Clinical guideline
Clinical guideline- Last updated: Oct 2015
- Published in Australia
- PPG #6
-
Transcranial Direct Current Stimulation (tDCS)
Electroconvulsive therapy & neurostimulation, Ethics, Professionalism
This memorandum is for psychiatrists who are interested in using transcranial direct current stimulation (tDCS) as a treatment for psychiatric disorders. PDF Clinical guideline
Clinical guideline- Last updated: Jul 2022
- Published in Australia
-
rTMS in hospitals
Electroconvulsive therapy & neurostimulation, Professionalism
Guidance on the delivery of Medicare-funded repetitive transcranial magnetic stimulation (rTMS) services in hospitals PDF Clinical guideline
Clinical guideline- Last updated: Nov 2021
- Published in Australia